The DOI matches its Crossref record.
Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 6
- Mahmood, 2018, Myocarditis in patients treated with immune checkpoint inhibitors, J Am Coll Cardiol, 71, 1755, 10.1016/j.jacc.2018.02.037 · DOI · Paper page
- Priemer, 2018, Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: a postviral autoimmune process?, J Neuropathol Exp Neurol, 77, 661, 10.1093/jnen/nly041 · DOI
- Muller, 2022, Diagnosis, risk stratification and management of myocarditis, Heart, 108, 1486, 10.1136/heartjnl-2021-319027 · DOI
- Cho, 2019, Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial, J Clin Oncol, 37, 2162, 10.1200/JCO.2017.77.3184 · DOI
- Giaccone, 2018, Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study, Lancet Oncol, 19, 347, 10.1016/S1470-2045(18)30062-7 · DOI
- Rajan, 2019, Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (avelumab) treatment in advanced thymoma, J Immunother Cancer, 7, 269, 10.1186/s40425-019-0723-9 · DOI
Cited by
Sorted by citations
Autoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51
Metadata
- Authors
- Cooper, L. T., Wolf, R. A., Plautz, G. E., Kratt, C., Lalchandani, V. B., & Bond, T. C.
- Corresponding author
- Cooper, Leslie T.
- Venue
- JACC: Advances
- Publisher
- Elsevier BV
- Published
- 2023-08
- Volume
- 2
- Issue
- 6
- Pages
- 100428
- ISSN
- 2772-963X (ISSN-L)
- PMC
- PMC11198541
- OpenAlex
- W4385325632
- Cited by
- 4
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- JACC Advances (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- myocarditis, immune checkpoint inhibitors, thymoma, immune-related adverse events, immune checkpoint inhibitor-associated myocarditis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
